Denis Chem Lab Limited carries a market capitalization of 1.13B, placing it among publicly traded companies globally. Its enterprise value stands at 528.47M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.13B |
| Enterprise Value | 528.47M |
Denis Chem Lab Limited currently has 13.88M shares outstanding.
| Shares Outstanding | 13.88M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Denis Chem Lab Limited trades at a trailing price-to-earnings ratio of 9.32. The price-to-sales ratio is 0.43, and the price-to-book ratio stands at 5.65.
| PE Ratio | 9.32 |
| PS Ratio | 0.43 |
| PB Ratio | 5.65 |
| P/TBV Ratio | 0.86 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Denis Chem Lab Limited trades at an EV/EBITDA multiple of 4.89 and an EV/FCF ratio of 88.92. The EV/Sales ratio of 0.29 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.89 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.29 |
| EV / EBITDA | 4.89 |
| EV / EBIT | 4.89 |
| EV / FCF | 88.92 |
Denis Chem Lab Limited maintains a current ratio of 2.70, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.57, indicating elevated leverage, while an interest coverage ratio of 12.86 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.70 |
| Quick Ratio | 0.94 |
| Debt / Equity | 4.57 |
| Debt / EBITDA | 0.39 |
| Interest Coverage | 12.86 |
Denis Chem Lab Limited posts a return on equity of 25.18 and a return on invested capital of 8.32.
| Return on Equity (ROE) | 25.18 |
| Return on Assets (ROA) | 7.09 |
| Return on Invested Capital (ROIC) | 8.32 |
| Return on Capital Employed (ROCE) | 25.08 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 9.57 |
Over the trailing twelve months, Denis Chem Lab Limited has paid 34.86M in income taxes, reflecting an effective tax rate of 29.30.
| Income Tax | 34.86M |
| Effective Tax Rate | 29.30 |
Denis Chem Lab Limited's stock has declined approximately -18.34249% over the past 52 weeks. The 50-day moving average sits at 73.83, while the 200-day moving average is 79.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | -18.34249% |
| 50-Day Moving Average | 73.83 |
| 200-Day Moving Average | 79.50 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Denis Chem Lab Limited generated 1.82B in revenue and converted that into 84.09M in net income, yielding earnings per share of 6.07. EBITDA reached 108.13M, while operating income came in at 108.13M.
| Revenue | 1.82B |
| Gross Profit | 840.03M |
| Operating Income | 108.13M |
| Pretax Income | 118.95M |
| Net Income | 84.09M |
| EBITDA | 108.13M |
| EBIT | 108.13M |
| Earnings Per Share (EPS) | 6.07 |
Denis Chem Lab Limited holds 296.84M in cash and equivalents against 41.85M in total debt, resulting in a net debt position of 32.73M. Total book value stands at 138.77M, with working capital of 536.77M providing operational flexibility.
| Cash & Cash Equivalents | 296.84M |
| Total Debt | 41.85M |
| Net Debt | 32.73M |
| Equity (Book Value) | 138.77M |
| Book Value Per Share | 10.01 |
| Working Capital | 536.77M |
Denis Chem Lab Limited operates with a gross margin of 46.23, reflecting its pricing power and cost economics. The operating margin of 5.95 and net profit margin of 4.63 provide insight into operational efficiency.
| Gross Margin | 46.23 |
| Operating Margin | 5.95 |
| Pretax Margin | 6.55 |
| Profit Margin | 4.63 |
| EBITDA Margin | 5.95 |
Denis Chem Lab Limited's most recent stock split took place on September 7, 2017 with a 200:211 split ratio.
| Last Split Date | 9/7/2017 |
| Split Ratio | 200:211 |
Denis Chem Lab Limited posts an Altman Z-Score of 3.67, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.67 |